Cited by 89Hormonal and reproductive studiesMenopause: Health Impacts and TreatmentsAdrenal Hormones and Disorders

The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission

Open access
Travison, Thomas G., Shackelton, Rebecca, Araujo, Andre B., Hall, Susan A., Williams, Rachel E., Clark, Richard V., O'Donnell, Amy B., McKinlay, John B.·2008·Journal of the American Geriatrics Society

Abstract

OBJECTIVES: To describe the onset, progression, and remission of symptomatic androgen deficiency (SAD) using longitudinal data from the Massachusetts Male Aging Study (MMAS). DESIGN: A prospective, population-based study of men living in Boston, Massachusetts. Data were collected in three waves: T1 (1987/89), T2 (1995/97), T3 (2002/04). Onset, progression, and remission were defined in terms of transitions in SAD status from one wave to the next. SETTING: In-person, in-home interviews. PARTICIPANTS: Seven hundred sixty-six community-dwelling men aged 40 to 70 at baseline (T1) contributed data from T1 to T2 and 391 from T2 to T3. MEASUREMENTS: SAD was defined in terms of serum total and free testosterone (T) levels and symptoms associated with low circulating androgens. Total T and sex hormone-binding globulin (SHBG) were measured using radioimmunoassay. Free T was calculated from total T and SHBG measurements. RESULTS: At T2 or T3, the likelihood of SAD was markedly greater for subjects who had exhibited SAD at the previous wave (odds ratio=3.8, 95% confidence interval=1.9-7.4), overall 55% of subjects who exhibited SAD experienced remission by the next study wave. The probability of SAD was greater with older age and greater body mass index. Multivariate models demonstrated that the likelihood of remission was at least 50% for most subpopulations. CONCLUSION: Over approximately 15 years of follow-up, SAD did not represent a stable health state. The likelihood of SAD would remit exceeded the likelihood that it would not, particularly among younger and leaner men.

Integrity signals

Registry

Crossref · 10.1111/j.1532-5415.2008.01679.x

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 52 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Travison, T. G., Shackelton, R., Araujo, A. B., Hall, S. A., Williams, R. E., Clark, R. V., O'Donnell, A. B., & McKinlay, J. B.
Affiliations
New England Research Institutes (US)
Corresponding author
Travison, Thomas G.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2008-05
Volume
56
Issue
5
Pages
831-839
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W1534951686
Cited by
89
References
52
Citations by year
2025: 3 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 10 · 2016: 4 · 2015: 6 · 2014: 9 · 2013: 6 · 2012: 7
FWCI
6.29
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Geriatrics Society (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • New England Research Institutes
  • National Institutes of Health (7p01ag004673-05)
  • National Institute on Aging (AG 04673, T32AG023482)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 51345, R01DK044995, DK44995, R01DK051345)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
male hypogonadism, testosterone, sex hormone-binding globulin, spontaneous regression, disease onset, disease progression, body mass index, older men, Massachusetts Male Aging Study
MeSH terms
Adult, Aged, Androgens, Boston, Cross-Sectional Studies, Humans, Hypogonadism, Longitudinal Studies, Male, Middle Aged, Reference Values, Remission, Spontaneous, Testosterone, Likelihood Functions, Disease Progression, Andropause

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review